<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084716</url>
  </required_header>
  <id_info>
    <org_study_id>R34MH119924</org_study_id>
    <nct_id>NCT05084716</nct_id>
  </id_info>
  <brief_title>Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk</brief_title>
  <official_title>PrEP Provision for Ugandan Fisherfolk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RAND</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mildmay Uganda Limited</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RAND</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a pilot test of enhancements to the standard of care for providing PrEP in&#xD;
      Ugandan fishing communities. The specific aims are to conduct a mixed-methods study assessing&#xD;
      enhancements to the standard of care for providing PrEP in fisherfolk communities in Lake&#xD;
      Victoria, Uganda.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will take place at two landing sites at which PrEP is provided to fisherfolk&#xD;
      through the national PrEP program. The control site will administer the standard of care for&#xD;
      PrEP provision through the national program. At the intervention site, we will implement a&#xD;
      three-pronged intervention:&#xD;
&#xD;
        1. During healthcare outreach events we will conduct PrEP workshops, in which people who&#xD;
           want to know more about PrEP can learn basic facts about PrEP and also can be taught&#xD;
           skills about how to advocate for PrEP in their community.&#xD;
&#xD;
        2. Check-in Calls: To support PrEP adherence, healthcare workers will call PrEP users&#xD;
           regularly (e.g., two weeks after initiation, and the week before refill events), to&#xD;
           check in about any questions and to remind them of the next date and place to pick up&#xD;
           refills. Calls after PrEP initiation will ask about side effects.&#xD;
&#xD;
        3. To support PrEP adherence, healthcare workers will encourage PrEP users to select an&#xD;
           adherence supporter, who is a family member or friend to whom they disclose their PrEP&#xD;
           use. The adherence supporter agrees to remind them to adhere to PrEP and get refills.&#xD;
           Healthcare workers will ask the PrEP user for the name and contact information for the&#xD;
           adherence supporter, so that the adherence supporter can be contacted to remind them&#xD;
           about refills, as well as if the PrEP user does not show up for a refill.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of time on PrEP</measure>
    <time_frame>Baseline to six months after</time_frame>
    <description>Number of months (0-6) that a participant is on PrEP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of people who accept PrEP of those offered</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of people who accept PrEP of those offered</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At the intervention site during healthcare facility outreach events, PrEP initiators will be offered guidance on selecting an adherence supporter during PrEP initiation. All outreach event attendees at the events will be offered the opportunity to attend the intervention workshops. Check-in reminder calls will be conducted systematically with PrEP users.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>At the control site, healthcare facility staff will continue to provide PrEP according to the standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced PrEP provision</intervention_name>
    <description>The intervention will train health care providers to facilitate workshops at outreach events where attendees can learn basic facts about PrEP and be taught skills about how to advocate for PrEP in their community. Healthcare facility staff will encourage PrEP initiators to select an adherence supporter. Check-in reminder calls will be conducted systematically with PrEP users.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Tests HIV-negative at a healthcare outreach/HIV testing event in one of the two&#xD;
             selected fishing communities and is PrEP-eligible&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not meeting the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura M Bogart, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RAND</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rhoda K Wanyenze, MBChB, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Makerere University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Bogart, PhD</last_name>
    <phone>310-393-0411</phone>
    <phone_ext>7281</phone_ext>
    <email>lbogart@rand.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terry Marsh, MPH</last_name>
    <phone>310-393-0411</phone>
    <phone_ext>6846</phone_ext>
    <email>tmarsh@rand.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Makerere University School of Public Health</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rhoda Wanyenze, MB ChB, PhD, MPH</last_name>
    </contact>
    <investigator>
      <last_name>Rhoda Wanyenze, PhD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mildmay Uganda</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Mukasa, MBChB, MPH</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PrEP</keyword>
  <keyword>Fisherfolk</keyword>
  <keyword>Uganda</keyword>
  <keyword>HIV/AIDS</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT05084716/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

